Atlas Trials

Hereditary Breast and Ovarian Cancer

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hereditary Breast and Ovarian Cancer

RecordFirmDate
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing (NCT05130606)Georgetown University2021-06-01
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome (NCT04508764)Washington University School of Medicine2021-04-09
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection (NCT04668521)Aspira Women's Health2020-05-04
Study of Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2 Mutation Carriers (BRCA-HRT) (NCT05409222)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau2020-03-12
Evaluation of the Adhesion to the GENEPY Network (NCT03979612)Institut Claudius Regaud2019-08-01
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. (NCT03246841)UNICANCER2017-09-21
Genetic Risk: Whether, When, and How to Tell Adolescents (NCT03421327)Johns Hopkins University2017-09-01
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment (NCT03511690)Georgetown University2017-07-01
Familial Investigations of Childhood Cancer Predisposition (NCT03050268)St. Jude Children's Research Hospital2017-04-06
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland (NCT03124212)University of Basel2017-04-01
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer (NCT03075540)Georgetown University2016-05-24
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer (NCT02786147)Emory University2016-04-01
Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers (NCT02516540)Technical University of Munich2015-03-01
Cancer Genetics Hereditary Cancer Panel Testing (NCT02324062)University of Southern California2014-06-12
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers (NCT02087592)Technical University of Munich2014-02-01
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry (NCT02302742)University of Kansas Medical Center2011-03-22

Track Hereditary Breast and Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.